Dipeptidyl peptidase-4 inhibitors and acute pancreatitisA systematic review of descriptive studies

被引：0
|
作者：
Basheer, Fathima Thashreefa
Acharya, Leelavathi D. [1 ]
Thunga, Girish [2 ]
Shetty, Rashmi [1 ]
Chandran, Viji Pulikkel [1 ]
Rashid, Muhammed [2 ]
机构：
[1] Manipal Acad Higher Educ, Dept Pharm Practice, Manipal Coll Pharmaceut Sci, Manipal, India
[2] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Manipal, India
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1282
引用
收藏
页码：597 / 597
页数：1
相关论文
共 50 条
  • [1] Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review of Structure-Activity Relationship Studies
    Bayanati, Maryam
    Rabbani, Mohammad Ismail Mahboubi
    Kabiri, Shirin Sirous
    Mir, Bahare
    Rezaee, Elham
    Tabatabai, Sayyed Abbas
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01):
  • [2] Tolerability of Dipeptidyl Peptidase-4 Inhibitors: A Review
    Richard, Kathleen R.
    Shelburne, Jamie S.
    Kirk, Julienne K.
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1609 - 1629
  • [3] PATIENT-REPORTED OUTCOMES OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS: A SYSTEMATIC REVIEW
    Franch, J.
    Perez, A.
    Lizan, L.
    Aceituno, S.
    Lopez, F.
    Fuster, E.
    Granell, M.
    VALUE IN HEALTH, 2014, 17 (07) : A355 - A355
  • [4] Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas
    Deacon, C. F.
    Lebovitz, H. E.
    DIABETES OBESITY & METABOLISM, 2016, 18 (04): : 333 - 347
  • [5] Dipeptidyl peptidase-4 inhibitors and osteoporosis
    Lee, Wen-Ling
    Lee, Fa-Kung
    Wang, Peng-Hui
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (09) : 889 - 890
  • [6] The role of dipeptidyl peptidase-4 inhibitors
    Lasserson, Daniel
    Mant, Jonathan
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [7] Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis
    Scheen, Andre
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 545 - 557
  • [8] Dipeptidyl peptidase-4 inhibitors and risk of arthralgia: A systematic review and meta-analysis
    Men, P.
    He, N.
    Song, C.
    Zhai, S.
    DIABETES & METABOLISM, 2017, 43 (06) : 493 - 500
  • [9] EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Perez, A.
    Franch, J.
    Fuster, E.
    Paz, S.
    Prades, M.
    Granell, M.
    VALUE IN HEALTH, 2014, 17 (07) : A335 - A336
  • [10] Renal outcomes with dipeptidyl peptidase-4 inhibitors
    Scheen, A. J.
    Delanaye, P.
    DIABETES & METABOLISM, 2018, 44 (02) : 101 - 111
12345